Prospective Grant of Partially-Exclusive Licenses: Human-Bovine Reassortant Rotavirus Vaccine

Riepilogo

This is notice, in accordance with 35 U.S.C. 209(c)(1) and 37 CFR 404.7(a)(1)(i), that the National Institutes of Health (NIH), Department of Health and Human Services, is contemplating the grant of partially exclusive licenses in (1) India; (2) China; and (3) Brazil to practice the invention embodied in U.S. Serial Number 60/094,425, filed July 28, 1998, PCT filed (PCT/US99/17036) on July 27, 1999, and National Stage filed in China, India, Korea, Australia, Canada, Europe, Japan, Brazil and the U.S., entitled "Multivalent Human-Bovine Rotavirus Vaccine" (DHHS ref. E-015-1998/0) as follows: (1) Co- exclusive licenses in India only to Biological E LTD, having a place of business in Hyderabad, India, and Bharat Biotech International LTD, having a place of business in Hyderabad, India; (2) non-exclusive licenses exclusively offered to companies and/or institutions within China; and (3) exclusive license in Brazil only to Fundacao Instituto Butantan, having a place of business in Sao Paolo, Brazil. The patent rights in these inventions have been assigned to the Government of the United States of America.